DDX53 and colonic neoplasm: It was reported previously that treatment with anti-PVRIG mAb alone shows no inhibitory effect on tumor growth in murine CT26 colon cancer model [26], consistent with their study, we observed no influence of anti-PVRIG mAb on CT26 tumor-bearing mice (data not shown).